Skip to main content

CSTK-06: Nimodipine Treatment Administered

CBE ID
2863
1.5 Project
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

Proportion of subarachnoid hemorrhage (SAH) patients age 18 years and older for whom nimodipine treatment was administered within 24 hours of arrival at this hospital.

This is the sixth measure in a set of measures developed for Joint Commission Comprehensive Stroke Certification. Although it is not required that these measures are reported in conjunction with each other, The Joint Commission develops measures in sets in order to provide as comprehensive a view of quality for a particular clinical topic as possible.

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      1.8 Level of Analysis
      1.9 Care Setting
      1.14 Numerator

      SAH patients for whom nimodipine treatment was administered within 24 hours of arrival at this hospital.

      1.15 Denominator

      SAH patients

      Exclusions

      • Patients less than 18 years of age
      • Patients who have a Length of Stay greater than 120 days
      • Patients with Comfort Measures Only documented on the day of or day after hospital arrival
      • Patients enrolled in Clinical Trials
      • Patients discharged within 24 hours of arrival at this hospital

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Neurology Fall Cycle 2019
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      The Joint Commission
      Steward POC email
      Steward Organization Copyright

      No royalty or use fee is required for copying or reprinting this manual, but the following are required as a condition of usage: 1) disclosure that the Specifications Manual is periodically updated, and that the version being copied or reprinted may not be up-to-date when used unless the copier or printer has verified the version to be up-to-date and affirms that, and 2) users participating in Joint Commission accreditation, including ORYX® vendors, are required to update their software and associated documentation based on the published manual production timelines.

                Public Comments